Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
7.17
+0.01 (0.14%)
At close: Mar 3, 2026, 4:00 PM EST
7.17
0.00 (0.00%)
After-hours: Mar 3, 2026, 4:53 PM EST
Replimune Group Employees
Replimune Group had 479 employees as of March 31, 2025. The number of employees increased by 148 or 44.71% compared to the previous year.
Employees
479
Change (1Y)
148
Growth (1Y)
44.71%
Revenue / Employee
n/a
Profits / Employee
-$657,313
Market Cap
590.81M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| MeiraGTx Holdings | 409 |
| Allogene Therapeutics | 229 |
| Rigel Pharmaceuticals | 164 |
| Ocugen | 95 |
| CorMedix | 65 |
| Larimar Therapeutics | 65 |
| Design Therapeutics | 55 |
| Contineum Therapeutics | 41 |
REPL News
- 1 day ago - Replimune to Present at Two Upcoming Investor Conferences - GlobeNewsWire
- 4 weeks ago - Replimune Reports Fiscal Third Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 6 weeks ago - Replimune Group, Inc. (REPL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - Replimune to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 3 months ago - The Short List — Top 10 Most Shorted Stocks Right Now - Benzinga
- 4 months ago - Replimune Presents Late-Breaking Abstract and Additional Posters on RP1 at 40th Annual Meeting of the Society for the Immunotherapy of Cancer (SITC 2025) - GlobeNewsWire
- 4 months ago - Replimune Reports Fiscal Second Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 4 months ago - Replimune Announces FDA Acceptance of BLA Resubmission of RP1 for the Treatment of Advanced Melanoma - GlobeNewsWire